Roquefort Therapeutics (ROQ) Insider Trading & Ownership GBX 3.92 +0.02 (+0.59%) (As of 12/20/2024 11:17 AM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider Trades Roquefort Therapeutics (LON:ROQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage60.40%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£102,532.26Number OfInsiders Selling(Last 3 Years)0 Get ROQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Roquefort Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROQ Insider Buying and Selling by Quarter Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Roquefort Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2023Dr Darrin DisleyInsiderBuy269,935GBX 7£18,895.457/12/2023Stephen Paul WestInsiderBuy15,730GBX 6£943.806/26/2023Stephen Paul WestInsiderBuy144,117GBX 7£10,088.196/23/2023Trevor Ajanthan (Ajan) ReginaldInsiderBuy35,265GBX 7£2,468.559/26/2022Dr Darrin DisleyInsiderBuy515,913GBX 8£41,273.047/4/2022Stephen Paul WestInsiderBuy210,000GBX 9£18,9006/30/2022Stephen Paul WestInsiderBuy55,147GBX 9£4,963.231/19/2022Stephen Paul WestInsiderBuy50,000GBX 10£5,000 (Data available from 1/1/2013 forward) ROQ Insider Trading Activity - Frequently Asked Questions Who is on Roquefort Therapeutics's Insider Roster? The list of insiders at Roquefort Therapeutics includes Dr Darrin Disley, Stephen Paul West, and Trevor Ajanthan (Ajan) Reginald. Learn more on insiders at ROQ. What percentage of Roquefort Therapeutics stock is owned by insiders? 60.40% of Roquefort Therapeutics stock is owned by insiders. Learn more on ROQ's insider holdings. Which Roquefort Therapeutics insiders have been buying company stock? The following insiders have purchased ROQ shares in the last 24 months: Dr Darrin Disley (£18,895.45), Stephen Paul West (£11,031.99), and Trevor Ajanthan (Ajan) Reginald (£2,468.55). How much insider buying is happening at Roquefort Therapeutics? Insiders have purchased a total of 465,047 ROQ shares in the last 24 months for a total of £32,395.99 bought. Roquefort Therapeutics Key ExecutivesMr. Stephen Paul West B.Com (Age 52)CA, Executive Chairman Compensation: $152.9kMr. Trevor Ajanthan Reginald (Age 52)CEO & Executive Director Compensation: $305.8kProf. Martin J. Evans FRS (Age 83)Group Chief Scientific Officer & Executive Director Compensation: $100kDr. Emma MorrisHead of Pre-Clinical Research More Insider Trading Tools from MarketBeat Related Companies ONC Insider Trades BVX Insider Trades FAB Insider Trades IXI Insider Trades OBD Insider Trades DEST Insider Trades RENE Insider Trades OCTP Insider Trades ONT Insider Trades GNS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:ROQ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROQ Stock Alerts